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Summary In this study, reverse transcriptase polymerase chain reaction was used to amplify human endothelin receptor A (ETA) and ETB
receptor mRNA. A truncated ETA receptor transcript with exons 3 and 4 skipped was found. The skipping of these two exons results in 109
amino acids being deleted from the receptor. The truncated receptor was expressed in all tissues and cells examined, but the level of
expression varied. In melanoma cell lines and melanoma tissues, the truncated receptor gene was the major species, whereas the wild-type
ETA was predominant in othertissues. A 1 .9-kb ETA transcript was identified in melanoma cell lines by Northem blot, which was much smaller
than the transcript in heart and in other tissues reported previously (4.3 kb). The cDNA coding regions of the truncated and wild-type ETA
receptors were stably transfected into Chinese hamster ovary (CHO) cells. The truncated ETA receptor-transfected CHO cells did not show
binding affinity to endothelin 1 (ET-1) or endothelin 3 (ET-3). The function and biological significance of this truncated ETA receptor is not
clear, but it may have regulatory roles for cell responses to ETs.
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Endothelins (ETs) are a 21 amino acid peptide family and consist
of three members. endothelin 1 (ET-1). endothelin 2 (ET-2) and
endothelin 3 (ET-3) (Inoue et al. 1989). In addition to acting as
strong vasoactixe peptides. they are potent mitocens for a Xaniety of
cells and play an essential role in the development of tissues and
cells derived from the neural crest. including melanocytes. The links
between ETs and many human diseases. such as cardiac ischaemia.
asthma and pulmonary hypertension. renal injuries. cancers and
some genetic disorders. have been established. The functions ofETs
are mediated by their receptors. Two ET receptors. endothelin
receptor A (ETA) and endothelin receptor B (ETB). have been char-
acterized in humans and other species (Arai etal. 1990: Hosoda et al.
1991: Ogawa et al. 1991: Sakurai et al. 1990). Both receptors belong
to the G-protein-coupled receptor superfamily. containing seven
transmembrane domains and signalling, through an intracellular G-
protein. The sequences of ET receptors are highly consened. espe-
ciallv in the transmembrane domains and intracellular loops. There
is 90% homology at the amino acid level within ETA or ETB recep-
tors across species barriers. and over60% homology between human
ETA and ETB. The typical FTA receptors have equal binding affini-
ties for EIF-1 and ET-2 but much lower affinities for ET-3. whereas
typical ETB receptors have equal binding affinities for all three ET
peptides. Howexer. studies have shown that many pharmacological
effects cannot be attributed to stimulation of either ETA or ETB
receptors (Bax et al. 1993: Mombouli et al. 1993: Riezebos et al.
1994). suggestinc other types of ET receptors or ET receptor xari-
ants exist. This studs was aimed at detecting ET receptor variants by
usin, suitable molecular strategies.
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MATERIALS AND METHODS
Materials
Superscript II reverse transcriptase xxas obtained from Gibco-BRL
Life Technology. Oligo(dT),, primers were obtained from
Pharnacia-LKB. RNasin RNase inhibitor Awas purchased from the
Promega Biotech Corporation. AmpliTaq and Cycle Sequencing
kits were purchased from Perkin Elmer Cetus. USA. All oliro-
nucleotide primers were synthesized by Genosy s Biotechnologies.
The Lipofectin reagent for transfection was obtained from Gibco-
BRL Life Technology. Chinese hamster ovary (CHO) cells were
obtained from the American Culture Collection. [I']ET-l and
['1-I]ET-3 were purchased from Amersham International. UK.
Normal human tissues were obtained at operation. Fetal heart
samples were from the MRC tissue bank. Melanoma tissues were
from metastatic lesions and kindly provided by the Department of
Histopathology. Royal Marsden Hospital (Dr Cyril Fisher). All
tissues were quickly frozen in liquid nitrogen and stored at - 80WC.
Melanoma cell lines w-ere kindlv provided by the Department of
Dermatology (Professor Tony Thody). University of Newcastle
Upon Tyne and cultured in Dulbecco's modified Eagle medium
supplemented with 10%7 fetal calf serum. 2 m-M glutamine and
penicillin (100 U ml-') streptomycin (100 ige ml-') in an incubator
with 5% of carbon dioxide supply in air.
Methods
RNA preparation
Total RNA was extracted from frozen tissues or cultured cell lines
with the single-step RNA extraction method (Chomczynski and
Sacchi. 1987). The quality of RNA was evaluated by checkincg the
integrity of 28S and 18S ribosome bands after electrophoresis. The
concentration ofRNA samples was measured by combining optical
densitv at 260 nm and staining, intensity and comparinga these with
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Table 1 RT-PCR reactions and primers used for amplification of human ETA cDNA
Reacbon Primer Direction Primer sequence Positon Expected Aim
see(bp)
1A AB1 F GTCATTGAYMTCCCTATCAATGT 391-413 731 Detect other ET receptorfamily members
AB2 R TTGCTCACMAAATACAGAGCWAT 1121-1099
2A A3 F CAGAACAAATGTATGAGGAATGGC 319-342 803 Detect ETA homologues
AB2 R TTGCTCACMAAATACAGAGCWAT 1121-1099
3A A5 F GCACAAGTGCAATAAGAGATAITTCC -42-(-)17 606 Detect functional variants
A4 R GCAACTGCTCTGTACCTGTC 563-544
4A A5 F GCACAAGTGCAATAAGAGATATTTCC -42-(-)17 1164 Amplify 5' half
AB2 R TTGCTCACMAAATACAGAGCWAT 1121-1099
5A ABi F GTCATTGAYMTCCCTATCAATGT 391-413 922 Amplify 3' half
A6 R GAGTACCGAGGAGTGCTTCTAAGG 1312-1289
F, forward. R. reverse.
Table 2 RT-PCR reactions and primers used for amplification of human ETB cDNA
Reacton Primer Direction Primer sequence Posiion Expectd Aim
sie (bp)
1B AB1 F GTCATTGAYMTCCCTATCAATGT 454-476 719 Detect other ET receptor family members
AB2 R TTGCTCACMAAATACAGAGCWAT 1172-1150
2B B3 F GGTCCMAATATCTTGATMGCCAGC 403-426 899 Detect ETB homologues
B4 R CGGAAGTTGTCRTATCCGTGATC 1301-1279
3B B5 F TGAGTCTATGTGCTCTRAGTATTG 569-592 478 Detect functonal variants
B6 R AGRGTGAGCTTCARAATCCTGCT 1046-1024
4B B7 F ATGCAGCCGCCTCCAAGTCTGTGC 0-24 1173 Amplify 5' half
AB2 R TTGCTCACMAAATACAGAGCWAT 1172-1150
5B AB1 F GTCATTGAYMTCCCTATCAATGT 454-476 854 Amplify 3' half
B8 R CTGGAACGGAAGTTGTCATATCC 1307-1285
F. forward. R, reverse.
a standard RNA sample in agarose-ethidium bromide gel.
Purification ofpoly (A)+ mRNA was carried out by using Oligotex
mRNA Mini Kit (Qiagen. Germany). Quality and quantity oftotal
RNA were evaluated before poly(A)- mRNA was purified and the
concentration ofpoly(A)+ was evaluated by measuring OD,,.
Reverse transcription polymerase chain reaction (RT-PCR)
to amplify ETA and ETB receptor cDNA
Primer designing strategies and RT-PCR reactions The
primers were designed using the published human ETA receptor
cDNA. human ETA receptor genomic DNA sequences (Hosoda et
al. 1991. 1992) and Genbank DNA sequencina data (L06622 for
human ETA cDNA sequence. X57765 for bovine ETA cDNA
sequence. M60786 for rat ETA cDNA sequence). A series of
RT-PCR reactions for ETA were performed usin, different
combinations of primers. Reaction 1A was performed using
pnmers designed wvithin the most homologous regions of human
ETA and ETB. and reaction 2A using the primers from the most
homologous regions among human. bovine and rat ETA. Because
transmembrane domains I-Ill plus intervening loops are important
to determine the selectivity of human ETA receptor (Sakamoto et
al. 1993: Becker et al. 1994). We. therefore. set reaction 3A to
amplify this 'functional re-ion'. Another two reactions were set to
amplify the 5' part (4A) and the 3' part (5A) of the cDNA of the
receptor respectively. The RT-PCR reactions and pnrmers used are
listed in Table 1.
Similar strategies were used for ETB primer design. The
primers were designed according to the published human ETB
receptor cDNA (Ogawa et al. 1991). human ETB receptor
genomic DNA sequences (Arai et al. 1993) and Genbank DNA
sequencing data (L06623 for human ETB cDNA. X57764 and
S65355 forrat ETB cDNA. D90456 forbovine ETB). Reaction lB
was performed using primers from the most homologous regions
ofhuman ETA and ETB: reaction 2B. using primers from the most
homologuous reDgions among human. bovine and rat ETB. Because
the transmembrane domain IV-VI plus intervening loops are
important to the selectivity of human ETB receptor (Sakamoto et
al. 1993: Becker. 1994). reactions to amplify this functional region
were performed (3B). Two further reactions were performed to
amplify the 5' region (4B) and the 3' region (SB) of the ETB
receptor cDNA. The RT-PCR reactions and primers used to
amplifv ETB are listed in Table 2.
RT-PCR procedure Total RNA (3 jg) was reserse transcribed
with 100 U of Superscript II in 20gl reaction volume. First. total
RNA was mixed with 0.5 go oligo(dT), , primers. The mixture
was heated to 70°C for 10 min and quickly chilled on ice. Then
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Figure 1 RT-PCR results of different reacions for amplifying human ETA
receptor cDNA. Lane M, 1-kb DNA marker, lane 1, G3PDH; lane 2, reaction
1A: lane 3, reaction 2A; lane 4, reaction 3A; lane 5. reacton 4A; lane 6.
reacton 5A. All reactions for ETA cDNA produced a strong band
corresponding to the wild-type ETA at the expected positon. Reactons 1A.
2A. 4A and 5A also yielded another weak band which was 327 bp smaller
than its corresponding nain band
100 U of Superscnrpt II. 40 U of RNasin RNase inhibitor. 0.75 Im
of dNTPs and 0.01 m DTT were added. The reaction was carried
out in a buffer containing 50 mm Tris-HCl. 75 mm potassium
chloride and 3 mm magnesium chloride at 42CC for 90 min and
then reverse transcriptase was inactivated by heating at 70°C for
15 min. Single strand cDNA (2 gl) was amplified for 35 cycles
(94CC for 1 min. 45 C for 1 min and 72'C for 3 min) in a solution
containing 200gj\i dNTPs. 0.5 gIm of each primer. 1.5 mm
magnesium chloride. 10 mm Tris-HCl. pH 8.3. 50 m-Ni potassium
chloride. 1 unit AmpliTaq DNA polymerase. Amplification of the
glyceraldehyde-3-phosphate dehydrogenase (G3PDH) gene was
used as an internal control. The sequences forG3PDH pnrmers are:
(forward) 5'-GCAAAT-TCCATGGCACCGTCA-3' (155-175).
(reverse) 5'-GTCATACCAGAAATGAGCTT-3' (939-919) (Tso
et al. 1985).
DNA sequencing analysis
PCR products or plasmid DNA containing cDNA inserts were
sequenced using an ABI377 automatic sequencer. Products were
sequenced in both directions. DNA sequencing reactions were
performed using a Cycle Sequencing kit containing fluorescence-
labelled terminators, and sequencing data were obtained using
an ABI377 automatic sequencer and analysed with Sequence
Navigator software.
Northem blotanalysis
Total RNAs from heart sample (20 jg). melanoma cell lines
(80 jg) and poly(A)+ RNA (1 jg) from melanoma cell lines were
separated on denaturing glyoxal-DMSO gels and transferred onto
Hybond-N membrane. Prehybridization was carried out in a
prehybridization solution containing 50% formamide. 6 x SSC.
5 x Denhardt's. 0.5% sodium dodecyl sulphate (SDS) and
100 jg mlF salmon sperm DNA at 42 C for 2 h. followed by
hybridization at 42CC for 20 h in prehybridization solution supple-
mented with 'P-labelled full-length ETA cDNA coding region.
After hybridization, the membranes were washed with 0.1 x
SSC/O.lc SDS for 20 min once at 45 C and twice at 65°C. and
then exposed to high-sensitivity films for 3-7 days at -80°C.
Expression ofETA in CHO cells
Truncated and full-length wild type ETA cDNA coding region.
amplified by RT-PCR. was subcloned into the neogene contain-
ing expression vector pLNCX (Miller and Rosman. 1989).
Recombinant DNA (2 gg) was transfected into 50%7 confluent
CHO cells growing in 60-mm cultured Petri dishes using
Lipofectin reagent. Transfected CHO cells were selected using
Figure 2 Expression of the full-ln and truncated ETA in different normal
tissues. Lane 1, saphenous vein; lane 2. aorta: lane 3. 16-week fetal heart:
lane 4, 12-week fetal heart; lane 5, liver, lane 6, skin. The DNA fragments at
803 bp correspond to the full-length ETA transcript. whereas the fragments at
476 bp correspond to the truncated ETA. Two transcripts are expressed in all
samples. Compared with the expression of the full-leng ETA. the truncated
ETA is expressed at low levels in saphenous vein, fetal heart, aorta, liver and
relativety higher levels in skin
Figure 3 Expression of the fuB-length and the truncated ETA transcnpts in
five different melanoma tumour tissues. Both transcripts are expressed in
every sample. The fragments at the positon of 803 bp correspond to the full-
length ETA and the bands at the position of 476 correspond to the truncated
ETA. The truncated ETA is expressed at a higher level than the full-length
ETA in samples 1, 2. 4 and 5. and at similar levels to the full-length ETA in
sample 3
800 g ml- of geneticin (Sigma. UK). Total RNA was extracted
from selected colonies and expression of both truncated and wild
type ETA mRNA was analysed by RT-PCR.
Binding study
Colonies demonstrated by RT-PCR to express high levels of the
truncated ETA receptor were cultured in selection medium and
detached with phosphate-buffered saline (PBS) supplemented with
6 mm EDTA. The cells were washed twice with ligand binding
buffer [RPMI-1640 medium. 0.5%7 bovine serum albumin (BSA).
25 mm HEPES. pH 7.2] and centrifuged for 5 min at 2000 r.p.m. at
4°C. Cells (2 x I0S) were incubated with [12I]ET-l or [''211ET-3
(50 pm-600 pm) in the presence or absence of 1000-fold excess of
unlabelled ET-1 or ET-3. After 2 h incubation at room temperature
with constant shaking. cells were quickly washed twice with ice-
cold liaand binding buffer. Radioactivitv bound to cells was
measured in a gamma counter (LKB-Wallac CliniGamma 1272).
Full-length wild type ETA-transfected CHO colony was chosen as
a positive control. and non-transfected CHO cells were used as
negative control.
RESULTS
Detection of truncated ETA by RT-PCR
All RT-PCR reactions for ETA produced DNA fragments of the
predicted sizes: 731 bp for reaction 1A: 803 bp for reaction 2A:
606 bp for reaction 3A: 1164 bp for reaction 4A and 922 bp for
reaction SA. In addition to the expected bands. a second weaker
band about 300 bp smaller than the expected band can be seen in
reactions IA. 2A. 4A and 5A (Figure 1). All PCR products were
recovered from the agarose gel using the Geneclean fII Kit (Bio
101. USA) and sequenced. Direct sequence analy sis demonstrated
that the main bands from each reaction were the predicted human
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Figure 4 Expression of ETA and ETB receptors in four melanoma cell lines (T8, DX3K, HMB2 and LT5.1). M, DNA 1-kb marker, G, G3PDH; ETA, ETA
receptor, ETB, ETB receptor. ETA is expressed at much lower levels than ETB in all melanoma cell lines. Of two ETA transcipts, the truncated one is expressed
at a higher level Ftan te wild type
[251]ET-1 binding
4.3 kb-
1.9kb-
Figure 5 Northem blot analysis of ETA mRNA transcript for melanoma cell
lines and normal heart sample. Full-length human ETA cDNA was used as a
probe. Total RNA (20 gg from a normal heart and 80 gg from three melanoma
cell lines) were separated on a denatured glyoxal-DMSO gel. Lane 1, LT5.1;
Lane 2, HMB2; lane 3, DX3K; lane 4, normral heart. A 4.3-kb transcript was
picked up in the heart sample. No signal at 4.3 kb was detected for all
melanoma samples. Instead, a signal at 1.9 kb was detected
ETA sequence. and the small bands from each reaction were
identical to the published sequence except that the regions
corresponding to exons 3 and 4 were skipped. This resulted in a
327-nucleotide deletion from the coding region of ETA. This
could cause the loss of 109 amino acids from the encoded protein.
RT-PCR for the ETB receptor resulted in amplification of a
single band of the predicted size. 719 bp for reaction lB. 899 bp
for reaction 2B. 478 bp for reaction 3B. 1173 bp for reaction 4B
and 854 bp for reaction 5B. Direct sequence analysis confirmed
that the amplified products were identical to the published
sequence for the human ETB receptor (data not shown).
Expression of truncated ETA receptor in melanoma cell
lines, melanomas and normal tissues
The expression of the truncated and wild type ETA receptor was
investigated in several normal human tissues. including aorta.
liver. skin. placental central arteries. placental central veins and
placental peripheral vessels and saphenous vein. The wild type
ETA receptor was expressed in all the normal tissues examined
(Figure 2). The truncated ETA was expressed at a low level in all
the normal tissues examined. except for skin. in which the level of
expression was relatively higher than other normal tissues. Two
fetal heart samples at 12 and 16 weeks were also examined and
showed a low-level expression ofthe truncated ETA receptor.
The expression of the truncated and wild-type ETA and ETB
was also investigated in five melanoma tumour tissues from
different patients. The ETB receptor mRNA was expressed in five
out offive melanomas examined, and expression ofboth wild-type
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Figure 6 Total [l251]ET-1 and [1'51]ET-3 binding to CHO cells transfected with
the truncated ETA cONA [CHO-ETA(t)], CFfo cels transfeted wih the wild
type ETA cDNA [CHO-ETA(w)] and non-trarsfected CHO cells. Increasing
concentrabons of [15I]ET-1 or [125]ET-3 was added to cells and bound
radioactvity was measured. CHO-ETA(w) showed saturable binding affinity to
[15I]ET-1, whereas CHO-ETA(t) and non-transfected CHO cells did not bind to
[12I]ET-1 or ['15]ET-3
ETA and truncated ETA was much lower than that of ETB in all
five samples (results not shown). Between the two ETA tran-
scripts. truncated ETA was expressed at a higher level than the
wild type in samples 1. 2. 4 and 5. and at a similar level to wild
type in sample 3 (Figure 3.)
The expression of the truncated ETA mRNA was further
investigated in several melanoma cell lines: DX3K. LT5.1. T8 and
HMB. All cell lines showed similar pattems of ET receptor
expression to melanoma tumours. ETA was expressed at very low
levels compared with ETB. The truncated ETA was the predomi-
nant ETA receptor type detected in all the melanoma cell lines
examined (Figure 4).
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Figure 7 Pre-mRNA splicing patterns and putative topography of human
trurcated and wild type ETA receptor. - represent exons and represent
introns. (A) truncated ETA receptor. Exons 3 and 4 are spliced out together
with their introns in its mature mRNA and encoded protein contains five
transmembrane domains, two extracellular and two intracellular loops. (B)
Wild-type ETA receptor. All exons are connected in order after all introns are
spliced out in consbtutive splicing. The region coloured in black is encoded
by exon 3 and exon 4
Northem blot analysis of ETA mRNA in melanoma cell
lines
Northern blot analysis identified a single band of 4.3 kb in total
RNA from a heart sample (20 go) after exposure for 3 days.
similar to the size reported in other human tissues (Hosoda et al.
1991). However. no product was seen in any ofthe melanoma cell
lines [1 jgc ofpoly(A+)]. even after exposure ofthe blot for 7 days.
Hybridization signals with the G3PDH probe confirmed roughly
equal loading of poly(A)+ and total RNA from the melanoma cell
lines and heart tissue (data not shown). Absence of ETA mRNA
detected by Northern blot suggested that the level ofETA receptor
expression was -ery low. In the melanoma cell lines. Northern blot
analysis using 80 g of total RNA from each of the melanoma
lines DX3K. LT5.1 and HMB, demonstrated a signal at 1.9 kb in
all the cell lines studied. after exposure to a high-sensitivity film
for 7 days. No signal at the position of4.3 kb was identified. corre-
sponding to the wild-type ETA (Figure 5).
Stable transfection of the truncated ETA cDNA and
ligand binding
The truncated and wild-type ETA cDNA coding regions were
stably transfected into CHO cells. as confirmed by RT-PCR. The
amount ofbound radioactivity ofthe cellsexpressing the truncated
ETA mRNA was similar to non-specific binding and showed a
linear relationship wvith the concentration of ET-1. indicating that
ET-1 did not bind to the cells. Cells expressing the wild-type ETA
showed saturable binding to ET-1. Neither truncated nor wild type
ETA-transfected cells bound ET-3 (Figure 6).
DISCUSSION
A truncated ETA mRNA transcript in which exon 3 and exon 4
have been skipped was identified by RT-PCR and is most probably
produced by alternative pre-mRNA splicing. In the constitutive
pre-mRNA splicing of ETA receptor genes. all introns are spliced
out and eig ht exons are subsequently connected in order.
producing wild-type ETA mRNA. In the truncated ETA transcript.
however. exons 3 and 4 are spliced out together with their introns.
exon 2 joining directly to exon 5. Previous studies have shown
exon 3 and exon 4 encode 109 amino acids. startinc from the
second amino acid of the first extracellular loop through trans-
membrane domain Ill. the second intracellular loop. then through
transmembrane domain IV until the amino terminus of the second
extracellular loop (Hosoda et al. 1992). The absence of exon 3 and
exon 4 will result in deletion of this area from the encoded protein
(Figure 7). This transcript has been described previously
(Miyamoto et al. 1996). Alternative pre-mRNA has been found in
numerous genes and such differential splicing is a very effective
way to generate functional diversity from a single gene.
Alternative splicing is known to exist in a number of the G-
protein-coupled receptor superfamilies. such as dopamine recep-
tors (Giros et al. 1991 ) and 5-hydroxytryptamine (5-HT) receptors
(Canton et al. 1996). Two human ETB variants produced by
alternative splicing have been reported (Shyarnala et al. 1994:
Elshourbagy et al. 1996).
It was shown in this study that the wild-type and truncated ETA
are widely expressed in manv normal tissues. The dominant
receptor RNA is the wild type. Both receptor mRNAs have also
been detected in fetal heart tissue as early as 12 weeks. However.
in melanoma cell lines and melanoma. the dominant receptor
mRNA type detected by RT-PCR is the truncated ETA receptor.
Using Northern blot analysis. the wild-type ETA mRNA was not
detected. demonstrating that the level of the wild-type ETA
expressed was very low in melanoma cell lines studied. The iden-
tification of a 1.9-kb band by Northern blot suggests that this
signal may be the truncated ETA mRNA.
ETs play an important role in the normal development of the
neural crest and of cells of neural crest origin. including
melanocvtes. Previous studies have shown that ETs can promote
the proliferation and differentiation of precursor melanocytes
(Reid et al. 1996). and a role for ETs in the biology of melanomas
has been suggested by several workers (Yohn et al. 1994: Kikuchi
et al. 1996). ET-1 is known to be a weak mitogen but a strong,
chemoattractant in melanoma cells (Yohn et al. 1994). sugg'esting
the importance of the role of ETs in the metastatic process of
melanoma. ETB receptors have been detected by Northern blot
analysis. RT-PCR and phannacological studies in a number of
melanoma cell lines. However. ETA mRNA has not been detected
by Northern blot analysis (Yohn et al. 1994). A possible reason for
this may be that not enough RNA was loaded. as our study showed
that the mRNA expression level ofETA in melanoma cells is very
low. Kikuchi et al (1996) did not detect ETA in several cell lines
from metastatic lesions even using RT-PCR. but this study used
primers in exons 3 and 4 for amplification. This explains the
discrepancy between our own RT-PCR data in melanoma cell lines
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and that of Kikuchi et al. because we have demonstrated exons 3
and 4 are absent in the tuncated ETA receptor mRNA.
Structural-functional studies have suggested that the amino
region (transmembrane I-Ill plus intervening loops) ofthe human
ETA receptor is the key region for ETA receptor selectivity, and
several amino acids in the boundary ofthe second transmembrane
domain and the first extracellular loop are important for binding
affinity for its ligand, ET-1 (Sakamoto et al, 1993; Adachi et al.
1994; Becker et al, 1994). The absence of the region encoded by
exons 3 and 4 will result in the lack of part of the functional
region. Ourbinding studies demonstrate thatabsence ofthisregion
resulted in loss ofbinding affinity for the ligand ET-1.
A previous study showed that split fragments at any intracel-
lular or extracellular loop (except at the first intracellular loop) of
a G-protein-coupled rat muscarinic acetylcholine receptor were
incorporated into the plasma membrane but the binding affinities
forits ligands was lost, suggesting thatplasma membrane insertion
of G-protein-coupled receptor does not require the presence of a
full-length receptor protein (Schoneberg et al, 1995). A truncated
form of 5-HT, receptor produced by alternative splicing did not
bind to its ligands, although it wasexpressed onthe cell membrane
(Canton et al, 1996). We suggest that the truncated ETA receptor
will still target the membrane with five transmembrane domains,
two extracellular and two intracellular loops, but different confor-
mation ofthe receptor may make it lose its binding affinity for its
ligand ET-1 and it may bind to some other ligand and play a
different role from wild type ETA. It may also interact with wild
type ETA/ETB receptors or other proteinsreceptors for ETs or
other cytokines to modulate their functions, or it may regulate
signal transduction pathways.
An altemative outcome, although less likely, is that the trun-
cated ETA may remain in the cytoplasm as a result ofthe protein's
conformational change and, thus, fulfil a new function. Examples
ofcytoplasmic truncated forms of membrane receptors have been
found in otherreceptor families (Faure et al, 1996).
In conclusion, a truncated human ETA receptor with exons 3
and 4 skipped because ofalternative pre-mRNA splicing has been
found in a variety of tissues, and the truncated tanscript is the
dominant ETA receptor mRNA in melanoma cell lines and
melanomas. The absence of the correspondingly encoded amino
acid region results in the loss of affinity for its ligand, ET-l.
Further studies will be needed to investigate its subcellular loca-
tion and its roles in cell growth.
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